Proton Pump Inhibitors Information - U S Food and Drug Administration Home Page
FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs) 3/2/2011 FDA Drug Safety Podcast: Risk of Low Magnesium Levels Associated with Long-Term Use of Proton Pump Inhibitors ...
www.fda.gov |